indazoles and pi103
indazoles has been researched along with pi103 in 4 studies
Research
Studies (4)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Alix, S; Box, G; Chuckowree, I; Clarke, PA; De Haven Brandon, A; Di Stefano, F; Eccles, SA; Folkes, A; Gowan, S; Hayes, A; Henley, AT; Lensun, L; McDonald, E; Patel, S; Pergl-Wilson, G; Raynaud, FI; Robson, A; Saghir, N; Sheldrake, P; Shuttleworth, S; Valenti, M; Wan, NC; Workman, P; Zhyvoloup, A | 1 |
| Clarke, PA; Raynaud, FI; van Montfort, RL; Workman, P | 1 |
| Mansley, MK; Wilson, SM | 1 |
| Dittmann, K; Fulda, S; Graab, U; Hahn, H; Marklein, D; Naumann, I; Nitzki, F; Ridzewski, R; Rosenberger, A; Wienands, J; Wojnowski, L; Yan, T | 1 |
Reviews
1 review(s) available for indazoles and pi103
| Article | Year |
|---|---|
Drugging the PI3 kinome: from chemical tools to drugs in the clinic.
Topics: Animals; Drug Delivery Systems; Furans; Humans; Indazoles; Models, Molecular; Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Sulfonamides | 2010 |
Other Studies
3 other study(ies) available for indazoles and pi103
| Article | Year |
|---|---|
Biological properties of potent inhibitors of class I phosphatidylinositide 3-kinases: from PI-103 through PI-540, PI-620 to the oral agent GDC-0941.
Topics: Administration, Oral; Animals; Cell Proliferation; Cells, Cultured; Endothelium, Vascular; Enzyme Inhibitors; Female; Furans; Glioblastoma; Humans; Indazoles; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Ovarian Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinases; Pyridines; Pyrimidines; Sulfonamides; Thiophenes; TOR Serine-Threonine Kinases; Umbilical Veins; Xenograft Model Antitumor Assays | 2009 |
Effects of nominally selective inhibitors of the kinases PI3K, SGK1 and PKB on the insulin-dependent control of epithelial Na+ absorption.
Topics: Absorption; Androstadienes; Animals; Benzoates; Benzylamines; Bridged Bicyclo Compounds, Heterocyclic; Cells, Cultured; Epithelial Cells; Furans; Immediate-Early Proteins; Indazoles; Insulin; Ion Transport; Kidney Tubules, Collecting; Membrane Potentials; Mice; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Pyridines; Pyrimidines; Quinoxalines; Sodium; Sulfonamides; Wortmannin | 2010 |
PI3K inhibition enhances doxorubicin-induced apoptosis in sarcoma cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; bcl-2-Associated X Protein; Caspase 3; Cell Line, Tumor; Cytochromes c; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Activation; Furans; Gene Expression; Humans; Indazoles; Mice; Mice, Nude; Multidrug Resistance-Associated Proteins; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Pyridines; Pyrimidines; Sarcoma; Sulfonamides; TOR Serine-Threonine Kinases; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |